Free Trial

Healthcare Stocks To Keep An Eye On - October 8th

UnitedHealth Group logo with Medical background

Key Points

  • MarketBeat identifies UnitedHealth Group, Hims & Hers Health, Tempus AI, Johnson & Johnson, and Novartis as healthcare stocks to watch due to their recent high trading volumes.
  • These companies represent various sectors within healthcare, including telehealth, precision medicine, and pharmaceuticals, aiming to address long-term growth driven by aging populations and medical innovation.
  • Investors are drawn to these stocks for their potential defensive characteristics and growth opportunities, particularly influenced by clinical-trial news and regulatory changes.
  • MarketBeat previews top five stocks to own in November.

UnitedHealth Group, Hims & Hers Health, Tempus AI, Johnson & Johnson, and Novartis are the five Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of companies operating in the medical and life-sciences sectors—such as pharmaceuticals, biotechnology, medical-device manufacturers, hospitals and healthcare service providers. Investors in healthcare stocks seek exposure to the industry’s long-term growth drivers, including aging populations, medical innovation and evolving regulatory landscapes. These equities can offer a mix of defensive characteristics and growth potential, often moving on clinical-trial news, policy changes and reimbursement developments. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read Our Latest Research Report on UNH

Hims & Hers Health (HIMS)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Read Our Latest Research Report on HIMS

Tempus AI (TEM)

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Read Our Latest Research Report on TEM

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Read Our Latest Research Report on JNJ

Novartis (NVS)

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology.

Read Our Latest Research Report on NVS

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2025 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines